20995 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Thymosin; Related peptides
PEPTIDE COMPOSITIONS FOR TREATING HAIR LOSS
#2METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#3ANTI-TUMOR PHARMACEUTICAL COMPOSITION BASED ON IMMUNE CHECKPOINT BLOCKADE AND USE THEREOF
#4USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
#5ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS
#6TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#7COMPOSITIONS AND METHODS FOR TREATING MYOCARDIAL INFARCTION AND ISCHEMIA
#8BETA THYMOSIN PEPTIDES FOR TREATING VIRAL INFECTIONS
#9Thymosin alpha 1 for use in treatment of cystic fibrosis
#10IMMUNOTHERAPEUTIC TREATMENT OF CANCER
#11COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS
#12PHARMACEUTICAL COMPOSITION CONTAINING GLY-THYMOSIN BETA-4 (GLY-TB4) FOR TREATMENT OF DRY EYE
#13Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
#14COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC GRANULOMATOUS DISEASE
#15METHODS OF TREATING COVID-19 PATHOGENESIS
#16Children Blood Transfusion and Thymus Hormonal Therapy as Antiviral and Antibacterial Compounds
#17Muscle cell patches and uses therefor
#18Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
#19METHODS OF TREATING DRY EYE SYNDROME
#20USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
#21METHOD OF TREATMENT OF IMMUNE CHECKPOINT INHIBITOR-RELATED IMMUNE ADVERSE EFFECTS
#22COMPOSITION FOR PROMOTING GOBLET CELL PROLIFERATION OR MUCIN SECRETION COMPRISING THYMOSIN BETA 4 OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT
#23METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION
#24Modulation of gene expression in a human bioreactor
#25Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
#26RECOMBINANT VECTORS
#27Methods and Compositions Useful for Treating Cancer
#28Compositions and methods for improving cardiac function
#29Thymosin alpha 1 for use in treatment of cystic fibrosis
#30Methods of treating dry eye syndrome
#31Pharmaceutical compositions with enhanced stability
#32Muscle cell patches and uses therefor
#33Multi-factor hair growth formulation
#34PEPTIDES FOR HAIR GROWTH
#35Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation
#36Stabilized external preparation comprising thymosin beta 4 as an active ingredient
#37USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
#38Method for preparing ophthalmic preparation containing thymosin beta-4
#39TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#40Recombinant vectors
#41Methods of making pharmaceutical compositions with enhanced stability
#42Thymosin alpha 1 for use in treatment of cystic fibrosis
#43LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
#44Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
#45Thymosin Beta 4 Promotes Wound Repair
#46Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells
#47EYE DROP FORMULATION
#48Wound healing using topical systems and methods
#49Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid
#50COMPOSITIONS AND METHODS FOR TREATING CORNEAL EPITHELIAL WOUND
#51Methods for the treatment of hepatitis B and hepatitis D infections
#52Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure
#53Muscle cell patches and uses therefor
#54Methods, systems, and compositions relating to miRNA-146a
#55Eye drop formulation
#56Wound healing using topical systems and methods
#57Treatment of cancer with immune stimulators
#58Recombinant vectors
#59Methods, systems, and compositions for promoting recovery of peripheral neuropathy
#60Composition and method for an intradermal hair growth solution
#61VARIANTS OF PROTHYMOSIN ALPHA AND METHODS OF USING SAME
#62USE OF THYMOSIN ALPHA FOR TREATMENT OF PURULENT RHINOSINUSITIS
#63USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
#64Methods for the treatment of hepatitis B and hepatitis D infections
#65Methods for the treatment of hepatitis B and hepatitis D infections
#66Wound healing using topical systems and methods
#67THYMOSIN ALPHA PEPTIDE FOR PREVENTING, REDUCING THE SEVERITY OF, AND TREATING INFECTION
#68Methods for the treatment of hepatitis B and hepatitis D infections
#69Methods for treating nervous system injury and disease
#70Oligonucleotide chelate complex—polypeptide compositions and methods
#71USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS
#72CANCER TREATMENT WITH RECOMBINANT VECTOR
#73Method of treatment of type 2 diabetes
#74HEPATITIS C THERAPIES
#75Treatment of infections with alpha thymosin peptides
#76Methods for treating nervous system injury and disease
#77THERAPEUTIC FUROPYRIMIDINES AND THIENOPYRIMIDINES
#78Macrocyclic inhibitors of hepatitis C virus replication
#79Agent for ameliorating blood-brain barrier disorders
#80Combinations for HCV Treatment
#81LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
#82Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
#83Methods for improving neurological outcome after neural injury and neurodegenerative disease
#84TREATMENT OF LEG ULCERS USING PLACENTA DERIVED COLLAGEN BIOFABRIC
#85Recombinant vectors
#86COMPOSITION FOR TREATMENT AND PREVENTION OF HAIR LOSS AND PREMATURE GRAYING OF HAIR
#87USE OF PEGYLATED TYPE III INTERFERONS FOR THE TREATMENT OF HEPATITIS C
#88TREATMENT OF INFECTIONS AND OTHER DISORDERS
#89THYMOSIN BETA 4 PROMOTES WOUND REPAIR
#90IMMUNOTHERAPY FOR REVERSING IMMUNE SUPPRESSION
#91METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (TB4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
#92TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)
#93TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH AN ANTINEOPLASTIC HEAT SHOCK APOPTOSIS ACTIVATOR (HSAA)
#94TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTIONS WITH ALPHA THYMOSIN PEPTIDES
#95Alpha thymosin peptides as vaccine enhancers
#96TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR
#97METHOD OF ADMINISTERING A THYMOSIN ALPHA 1 PEPTIDE
#98USE OF THE PEPTIDE COMBINATION THYMOSIN BETA 4 AND DELTA SLEEP INDUCING PEPTIDE AS A THERAPEUTIC AGENT
#99Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
#100TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES
#101Hepatitis C therapies
#102Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions
#103Treatment of Melanoma With Alpha Thymosin Peptides
#104Combinations for HCV Treatment
#105USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES
#106Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
#107USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ALLERGIES
#108Method of treatment for ischemic heart disease
#109METHOD OF TREATING PREVENTING, INHIBITING OR REDUCING DAMAGE TO CARDIAC TISSUE
#110Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma
#111Methods of Treating or Preventing Tissue Damage Caused by Increased Blood Flow
#112NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#113Use of thymosin alpha 1 for the treatment of immunological diseases
#114Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
#115LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE
#116LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
#117Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
#118Controlled release formulations
#119Thymosin beta 4 compositions and methods
#120Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions
#121Therapeutic furopyrimidines and thienopyrimidines
#122Treatment of Melanoma with Alpha Thymosin Peptides
#123NFκB transcriptional activity inhibitory agent and anti-inflammatory agent and a steroid action enhancing agent
#124Methods for treating nervous system injury and disease
#125Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#126Lkktet and/or Lkktnt Peptide Compositions and Methods
#127METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
#128TREATMENT OF INFECTIONS AND OTHER DISORDERS
#129Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma
#130USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA
#131Composition and method of treating hepatitis C
#132Pharmaceutical compositions with enhanced stability
#133Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
#134Treatment of infections with alpha thymosin peptides
#135Compositions and methods for promoting wound healing and tissue repair
#136Macrocyclic inhibitors of hepatitis C virus replication
#137Treatment or prevention of respiratory viral infections with alpha thymosin peptides
#138Treatment of leg ulcers using placenta derived collagen biofabric
#139Treatment of skin, and wound repair, with thymosin beta 4
#140Treatment of skin, and wound repair, with thymosin beta 4
#141Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
#142Methods of inhibiting viral infection
#143Treatment or prevention of damage due to radiation exposure
#144Hepatitis C therapies
#145Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#146Treatment of glioblastoma with thymosin-alpha 1
#147Therapeutic furopyrimidines and thienopyrimidines
#148Treatment of infections and other disorders
#149Method of up-regulating tumor antigen expression using thymalfasin
#150Combinations for HCV treatment
#151Methods and compositions for the promotion of a hair growth utilizing actin binding peptides
#152Thymosin augmentation of genetic immunization
#153Method of administering a thymosin alpha 1 peptide
#154Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
#155Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives